Chlorthalidone NDC 64980-303

NDC codes

FDA NDC Directory

Product NDC (as listed)64980-303Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64980-0303Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
64980-303-01	64980030301	100 TABLET in 1 BOTTLE, PLASTIC (64980-303-01)Marketed from May 17, 2017
64980-303-10	64980030310	1000 TABLET in 1 BOTTLE, PLASTIC (64980-303-10)Marketed from May 17, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Chlorthalidone
Generic name (nonproprietary): chlorthalidone
Active ingredients: Chlorthalidone — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Rising Pharma Holdings, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206904
Marketing start: May 17, 2017
Marketing end: Jan 31, 2027
Other FDA classes: Increased Diuresis (Physiologic effect)
Identifiers: Product ID 64980-303_94ef7a73-3872-4d19-bdde-881862337783SPL ID 94ef7a73-3872-4d19-bdde-881862337783SPL set ID f96b2d0b-a141-4efb-8ccc-c447dfc6024aRxCUI 197499, 197500UNII Q0MQD1073QUPC 0364980304016, 0364980303019
Pharmacologic class: Thiazide-like Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464980030301 followed by a unit qualifier and the quantity

Package 64980-0303-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 29, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. Chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Chlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Usage in Pregnancy: The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206904

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206904
Product	Strength	Form · route	Labeler	Product NDC
Chlorthalidone	Chlorthalidone 50 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-304
Chlorthalidone	Chlorthalidone 25 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-472